Hooper
Hooper, licence 80115591: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- GRANDIS PHARMACEUTICALS INC
- NPN or DIN-HM
- 80115591
- Status
- Active licence
- Licence date
- 18 January 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Collagène hydrolysé Source : Collagène hydrolysé | 210.0 mg | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine sulfate | 250.0 mg | Not calculated |
| Sulfate de chondroïtine Source : Sulfate de chondroïtine | 150.0 mg | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 150.0 mg | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 255.0 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 3.0 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 3.0 mg | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 20.0:1.0 Dry plant equivalent : 600.0 mg | 30.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 6.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintaining healthy cartilage and/or joint health. Helps to protect against the deterioration of cartilage. Helps to reduce joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80115591
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.